An agent is described that, with the help of glucose isomerase, convertsfructose into glucose and thus, alone or incombination with 5-D-fructose dehydrogenase, reduces the bioavailability offructose in the human or animal body. This agent canbe used in particular in the therapy of fructose intolerance.